ARTICLE | Financial News
Trevena planning $40M follow-on
November 21, 2014 2:56 AM UTC
Neurology company Trevena Inc. (NASDAQ:TRVN) proposed to raise $40 million in a follow-on underwritten by Barclays; Cowen; Jefferies; JMP; and Needham.
Trevena is developing GPCR ligands that activate or block specific signaling pathways mediated through individual GPCRs. ...